Back
Global X Artfcl Intlgc & Tech ETF Vs. Intra-Cellular Therapies Industry Stock Comparison
Buy
60
AIQ
Global X Artfcl Intlgc & Tech ETF
Last Price:
32.07
Seasonality Move:
9.01%
Sell
37
ITCI
Intra-Cellular Therapies
Last Price:
71.85
Seasonality Move:
4.56%
Buy
60
Global X Artfcl Intlgc & Tech ETF (AIQ)
is a Buy
Is Global X Artfcl Intlgc & Tech ETF a Buy, Sell or Hold?
- The current Global X Artfcl Intlgc & Tech ETF [AIQ] share price is $32.76. The Score for AIQ is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- AIQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $72.30. The Score for ITCI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AIQ Stock Price Chart
What is Global X Artfcl Intlgc & Tech ETF's stock price today?
-
The Global X Artfcl Intlgc & Tech ETF share price today is $32.76
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AIQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $72.30
The current trend is moderately bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
AIQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 47.7 | Sell |
| Chaikin Money Flow: | 192699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.4 - 34.06) | Sell |
| Bollinger Bands (100): | (30.87 - 33.61) | Buy |
ITCI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.38 | Buy |
| Relative Strength Index (14 RSI): | 53.26 | Buy |
| Chaikin Money Flow: | -346308 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (66.59 - 73.79) | Buy |
| Bollinger Bands (100): | (65.08 - 72.16) | Buy |
AIQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.24 | Buy |
| 20-day SMA: | 33.03 | Sell |
| 50-day SMA: | 33.33 | Sell |
| 200-day SMA: | 30.11 | Buy |
| 8-day EMA: | 32.51 | Buy |
| 20-day EMA: | 32.84 | Sell |
| 50-day EMA: | 32.89 | Sell |
| 200-day EMA: | 30.35 | Buy |
ITCI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 72.98 | Sell |
| 20-day SMA: | 70.61 | Buy |
| 50-day SMA: | 69.4 | Buy |
| 200-day SMA: | 62.33 | Buy |
| 8-day EMA: | 72.67 | Sell |
| 20-day EMA: | 71.32 | Buy |
| 50-day EMA: | 69.65 | Buy |
| 200-day EMA: | 64.15 | Buy |
Global X Artfcl Intlgc & Tech ETF Earnings Growth & AIQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.07 per share, an increase this year of $0.98 per share, and an increase next year of $1.45 per share.
Global X Artfcl Intlgc & Tech ETF Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Intra-Cellular Therapies Technical Analysis
| Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||